Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 9 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. US 11013798

    Orf virus-based platform for vaccine delivery

    SOUTH DAKOTA BOARD OF REGENTS · Granted May 25, 2021 · Expires May 20, 2041

    granted

  2. US 11007255

    Cancer vaccines and methods of treatment using the same

    Inovio Pharmaceuticals, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted

  3. US 11007265

    Vaccines having an antigen and interleukin-21 as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted

  4. US 11007263

    Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L

    The United States of America, as represented by the Secretary of Agriculture · Granted May 18, 2021 · Expires May 13, 2041

    granted

  5. US 11007261

    Compositions and methods of vaccination against dengue virus in children and young adults

    Takeda Vaccines, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted

  6. US 10980872

    Genetically stable live attenuated respiratory syncytial virus vaccine and its production

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  7. US 10967058

    Foot-and-mouth disease vaccine

    United States of America as represented by the Secretary of the Air Force · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted

  8. US 10947277

    Nucleic acids encoding zika virus-like particles and their use in zika virus vaccines and diagnostic assays

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  9. US 10933130

    Vaccines with interleukin-33 as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

  10. US 10925961

    Vaccines with CD40 ligand as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

  11. US 10925945

    Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereof

    Providence Health & Services—Oregon · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

  12. US 10905755

    Vaccines for human papilloma virus and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  13. US 10905752

    VEGFR-2 targeting DNA vaccine for combination therapy

    Vaximm AG · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  14. US 10898566

    Zika virus vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  15. US 10894078

    HIV vaccines comprising one or more population episensus antigens

    Vir Biotechnology, Inc. · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  16. US 10881722

    Epizootic hemorrhagic disease vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

  17. US 10869920

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  18. US 10865389

    DNA vaccines against foot-and-mouth disease virus

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  19. US 10858634

    Vaccines and pharmaceutical compositions against foot-and-mouth disease virus

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted

  20. US 10857225

    Smallpox vaccine for cancer treatment

    Calidi Biotherapeutics, Inc. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted

  21. US 10849975

    Multivalent vaccines for rabies virus and filoviruses

    The United States of America, as Represented by the Secretary, Department of Health and Human Services Services · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  22. US 10844357

    Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines

    The Board of Regents for Oklahoma State University · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted

  23. US 10837003

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  24. US 10835595

    PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy

    Inovio Pharmaceuticals, Inc. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.